play_arrow

keyboard_arrow_right

skip_previous play_arrow skip_next
00:00 00:00
playlist_play chevron_left
volume_up
chevron_left
  • Home
  • keyboard_arrow_right Featured

Featured

8 Results / Page 1 of 1


Background
eCritCare Podcast
play_arrow
share playlist_add
close

evidence based medicine

Double Sequential External Defibrillation – A game-changer

Dr Swapnil Pawar January 1, 2023

play_arrow Double Sequential External Defibrillation – A game-changer Dr Swapnil Pawar   Alternate defibrillation strategies for refractory ventricular fibrillation Cheskes S, Verbeek PR, Drennan IR, et al.  N Engl J Med. 2022 Nov 24;387(21):1947-1956. doi: 10.1056/NEJMoa2207304. Epub 2022 Nov 6. PMID: 36342151.   Blog Written by Dr Jose Chacko Background […]

eCritCare Podcast
play_arrow
share playlist_add
close

evidence based medicine

TEAM Trial – Early Mobilisation in Intensive Care

Dr Swapnil Pawar December 16, 2022

play_arrow TEAM Trial – Early Mobilisation in Intensive Care Dr Swapnil Pawar   Early Active Mobilization during Mechanical Ventilation in the ICU The TEAM Study Investigators and the ANZICS Clinical Trials Group Blog Written by – Dr Jose Chacko  Population and setting The study was held from February 27, 2018, […]

eCritCare Podcast
insert_link share playlist_add
close

evidence based medicine

CLASSIC Trial – Liberal vs Restrictive Fluid strategy in Septic Shock – Less is More?

Dr Swapnil Pawar July 9, 2022

The CLASSIC trial  Blog written by Dr Jose Chacko  Setting and design The CLASSIC trial was a multicentric randomized clinical trial carried out in 31 ICUs in Denmark, Norway, Sweden, Switzerland, Italy, the Czech Republic, the United Kingdom, and Belgium. The study was conducted over a 3-year period between November […]

eCritCare Podcast
play_arrow
share playlist_add
close

evidence based medicine

MICHELLE Trial – Rivaroxaban in COVID-19

Dr Swapnil Pawar January 30, 2022

play_arrow MICHELLE Trial – Rivaroxaban in COVID-19 Dr Swapnil Pawar Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial Blog Written by – Dr Jose Chacko Question: In patients hospitalized with COVID-19, does prophylaxis with rivaroxaban 10 mg/day for 35 days […]

eCritCare Podcast
play_arrow
share playlist_add
close

evidence based medicine

Neuromuscular Blockade in Intensive Care – To Be or Not To Be

Dr Swapnil Pawar April 9, 2021

play_arrow Neuromuscular Blockade in Intensive Care – To Be or Not To Be Dr Swapnil Pawar   Blog Slides by – Dr Swapnil Pawar Indications for NMB use in ICU – NMB Agents – NMB Monitoring – Evidence – ARDS –   Status Asthmaticus – Raised ICP/Severe TBI – Therapeutic […]

eCritCare Podcast
play_arrow
share playlist_add
close

evidence based medicine

Oxygen Therapy in ICU- The Circle of Uncertainty

Dr Swapnil Pawar March 5, 2021

play_arrow Oxygen Therapy in ICU- The Circle of Uncertainty Dr Swapnil Pawar   Background  Clinical practice guidelines give no recommendation for oxygenation targets in adult patients in the ICU owing to sparse evidence. Meta-analysis 2018 Meta-Analysis 2018 ICU-ROX Results LOCO2 Trial HOT- ICU Trial Setting: 35 ICUs in Denmark, Switzerland, […]